Sign In

Joey Azofeifa

Founder & CEO of Arpeggio Bio

Joey Azofeifa is the CEO and co-founder of Arpeggio Bio, a biotech startup focused on fighting drug resistance in cancer.2 Here are some key details about Joey:

Professional Background

Joey has a diverse background spanning biology, computer science, and data science:

  • He founded Arpeggio Bio in February 2019 and has since raised over $20 million in venture funding.24
  • Prior to Arpeggio, he worked as a Data Scientist at Forma Therapeutics and as a Bioinformatics Scientist at Merck.2
  • He has extensive experience in machine learning, probabilistic modeling, data visualization, and database management.3

Education

  • Ph.D. in Computer Science from the University of Colorado Boulder, focusing on applying machine learning to massive transcriptomic datasets.1
  • Undergraduate degree in Biology from Vassar College.3

Achievements and Recognition

  • Named to Forbes 30 Under 30 in Healthcare in November 2019.2
  • Selected for Colorado BizWest's 40 Under 40 in September 2023.2
  • Participated in Y Combinator's S19 batch.3

Arpeggio Bio

Under Joey's leadership, Arpeggio Bio has:

  • Developed an automated laboratory that profiles thousands of drugs for changes in RNA.2
  • Built the world's largest database of nascent RNA drug profiles.2
  • Partnered with over 40 pharmaceutical companies, including Novartis, Pfizer, and Genentech.2
  • Focused on developing new medicines to alter gene expression and combat drug resistance in cancer.5

Joey's work at Arpeggio Bio combines his expertise in bioinformatics, AI, and molecular biology to advance drug discovery and improve our understanding of human disease.1

Highlights

Apr 3 · linkedin

And here is another amazing story that Arpeggio will be featuring at AACR this year: our GPX4 inhibitor synergizes with anti-PDL1 in an extremely aggressive sarcoma mouse model. Again, so proud of the Arpeggio team and everything we have accomplished! #AACR #Ferroptosis #AI #Transcriptomics

Apr 3 · linkedin

We are repping AACR hard this year! I am so proud of the Arpeggio team for the discovery and optimization of an NRF2 degrader that completely prevents tumor growth in animals. Please hit me up if you will be at AACR! #AACR #TranscriptionFactor #AI #DrugDiscovery

Related Questions

What inspired Joey Azofeifa to start Arpeggio Bio?
How does Arpeggio Bio's technology work to combat drug resistance in cancer?
What are some of the key achievements of Joey Azofeifa in his career?
How did Joey's experience at Y Combinator influence his entrepreneurial journey?
What partnerships has Arpeggio Bio formed with pharmaceutical companies?
Joey Azofeifa
Joey Azofeifa, photo 1
Joey Azofeifa, photo 2
Add to my network

Experience

Founder & CEO at Arpeggio Bio (February 2019 - Present)
Data Scientist at Forma Therapeutics (August 2016 - January 2019), Bioinformatics Scientist at Merck (June 2017 - May 2018)

Location

Boulder, Colorado, United States